Literature DB >> 16103125

Structure and lytic activity of a Bacillus anthracis prophage endolysin.

Lieh Yoon Low1, Chen Yang, Marta Perego, Andrei Osterman, Robert C Liddington.   

Abstract

We report a structural and functional analysis of the lambda prophage Ba02 endolysin (PlyL) encoded by the Bacillus anthracis genome. We show that PlyL comprises two autonomously folded domains, an N-terminal catalytic domain and a C-terminal cell wall-binding domain. We determined the crystal structure of the catalytic domain; its three-dimensional fold is related to that of the cell wall amidase, T7 lysozyme, and contains a conserved zinc coordination site and other components of the catalytic machinery. We demonstrate that PlyL is an N-acetylmuramoyl-L-alanine amidase that cleaves the cell wall of several Bacillus species when applied exogenously. We show, unexpectedly, that the catalytic domain of PlyL cleaves more efficiently than the full-length protein, except in the case of Bacillus cereus, and using GFP-tagged cell wall-binding domain, we detected strong binding of the cell wall-binding domain to B. cereus but not to other species tested. We further show that a related endolysin (Ply21) from the B. cereus phage, TP21, shows a similar pattern of behavior. To explain these data, and the species specificity of PlyL, we propose that the C-terminal domain inhibits the activity of the catalytic domain through intramolecular interactions that are relieved upon binding of the C-terminal domain to the cell wall. Furthermore, our data show that (when applied exogenously) targeting of the enzyme to the cell wall is not a prerequisite of its lytic activity, which is inherently high. These results may have broad implications for the design of endolysins as therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103125     DOI: 10.1074/jbc.M502723200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  A hidden metabolic pathway exposed.

Authors:  Andrei Osterman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-04       Impact factor: 11.205

2.  Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.

Authors:  Peter Sass; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

3.  Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci.

Authors:  Marianne Horgan; Gary O'Flynn; Jennifer Garry; Jakki Cooney; Aidan Coffey; Gerald F Fitzgerald; R Paul Ross; Olivia McAuliffe
Journal:  Appl Environ Microbiol       Date:  2008-12-01       Impact factor: 4.792

4.  O-glycosylation as a novel control mechanism of peptidoglycan hydrolase activity.

Authors:  Thomas Rolain; Elvis Bernard; Audrey Beaussart; Hervé Degand; Pascal Courtin; Wolfgang Egge-Jacobsen; Peter A Bron; Pierre Morsomme; Michiel Kleerebezem; Marie-Pierre Chapot-Chartier; Yves F Dufrêne; Pascal Hols
Journal:  J Biol Chem       Date:  2013-06-12       Impact factor: 5.157

5.  Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.

Authors:  Lieh Yoon Low; Chen Yang; Marta Perego; Andrei Osterman; Robert Liddington
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 6.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

Review 7.  Recombinant bacteriophage lysins as antibacterials.

Authors:  Mark Fenton; Paul Ross; Olivia McAuliffe; Jim O'Mahony; Aidan Coffey
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

8.  Molecular aspects and comparative genomics of bacteriophage endolysins.

Authors:  Hugo Oliveira; Luís D R Melo; Sílvio B Santos; Franklin L Nóbrega; Eugénio C Ferreira; Nuno Cerca; Joana Azeredo; Leon D Kluskens
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 9.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

10.  Structural basis of cell wall cleavage by a staphylococcal autolysin.

Authors:  Sebastian Zoll; Bernhard Pätzold; Martin Schlag; Friedrich Götz; Hubert Kalbacher; Thilo Stehle
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.